[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1977

Treatment of Morphea-Type Basal Cell Carcinomas With Radiation Therapy

Author Affiliations

From the Oncology (Drs Bart and Kopf) and Physiotherapy (Dr Gladstein) Sections of the Skin and Cancer Unit, New York University Medical Center, and the Department of Dermatology, New York University School of Medicine.

Arch Dermatol. 1977;113(6):783-786. doi:10.1001/archderm.1977.01640060079009
Abstract

• Eight patients received superficial x-ray therapy for morphea-type basal cell carcinomas. Seven lesions did not recur. One recurrence adjacent to an irradiated field was observed; it was considered to be a geographic miss and has led us to include a wider field (10 mm) of normalappearing skin beyond the clinical perimeter of the tumor when the lesion is illdefined. The cosmetic results after treatment were poorer than anticipated for this schedule of radiation therapy, based on our extensive experience with other types of basal cell carcinomas.

To obtain the best long-term results we believe that, where technically feasible, Mohs surgery and conventional surgical excision with histologic verification of free margins are the treatments of choice for morphea-type basal cell carcinomas. However, our experience indicates that morphea-type basal-cell carcinomas can be cured with radiation therapy; therefore, x-rays have a place in the armamentarium of therapeutic modalities for this tumor if surgery is not feasible or if it is refused by the patient.

(Arch Dermatol 113:783-786, 1977)

×